SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Net Sales | ₹263 Cr | ₹224 Cr | ₹220 Cr | ₹18,482,242 Cr | ₹184 Cr |
What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹263 Cr |
| Mar2024 | ₹224 Cr |
| Mar2023 | ₹220 Cr |
| Mar2022 | ₹18,482,242 Cr |
| Mar2017 | ₹184 Cr |
How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹263 Cr | 17.45 | |
| Mar2024 | ₹224 Cr | 2.09 | |
| Mar2023 | ₹220 Cr | -100.00 | |
| Mar2022 | ₹18,482,242 Cr | 10,050,222.98 | |
| Mar2017 | ₹184 Cr | - | |
Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,317.9 Cr | -2.2% | 8.3% | -22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -2.2% |
8.3% |
-22.8% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses